Hjem › Juvenil myelomonocytisk leukemi › New York › New York City
Kliniske studier for Juvenil myelomonocytisk leukemi i New York City, NY
3 studier for Juvenil myelomonocytisk leukemi søker deltakere på steder i og rundt New York City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
RekruttererFase 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
RekruttererFase 1
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Juvenil myelomonocytisk leukemi-studier i andre byer
- Minneapolis, MN4 studier
- Philadelphia, PA4 studier
- Boston, MA3 studier
- Chicago, IL3 studier
- Atlanta, GA3 studier
- Memphis, TN3 studier
- Indianapolis, IN3 studier
- Washington, DC3 studier
- Cincinnati, OH3 studier
- Ann Arbor, MI3 studier
- San Francisco, CA3 studier
- Seattle, WA3 studier
Andre studier i New York City
- Brystkreft136 studier
- Ikke-småcellet lungekreft121 studier
- Kreft (alle typer)109 studier
- Prostatakreft103 studier
- Metastatisk kreft93 studier
- Kolorektal kreft78 studier
- Eggstokkreft69 studier
- Lungekreft60 studier
- Multipelt myelom60 studier
- Pankreaskreft60 studier
- Endometriekreft52 studier
- Akut myelogen leukemi51 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.